论文信息 - Sorafenib plus interferon-α2b (IFN) as first-line therapy for advanced renal cell carcinoma (RCC): SWOG 0412. - 字舞流文

Sorafenib plus interferon-α2b (IFN) as first-line therapy for advanced renal cell carcinoma (RCC): SWOG 0412.

C. Ryan | H. Drabkin | T. Beer | P. Lara | B. Goldman | E. Crawford | T. M. Beer | Christopher W. Ryan | Primo N. Lara | H. A. Drabkin